Maria Rosaria Sorrentino

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 290 citations

Medicine, Endocrinology, Pharmacology +11

Estimation of Mortality Risk in Type 2 Diabetic Patients (ENFORCE): An Inexpensive and Parsimonious Prediction Model

Massimiliano Copetti, Hetal Shah, Andrea Fontana et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 19 citations · Full text

Medicine, Biostatistics, Internal Medicine +17

Cardio-ankle vascular index is associated with diabetic retinopathy in younger than 70 years patients with type 2 diabetes mellitus

Olga Lamacchia, Maria Rosaria Sorrentino, Giuseppe Picca et al. · Diabetes Research and Clinical Practice · 2019 · 12 citations · Full text

Medicine, Ophthalmology, Clinical Optometry +13

Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care

Mario Luca Morieri, Riccardo Candido, Simona Frontoni et al. · Diabetes Therapy · 2023 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15